InsiderInsights.com Daily Round Up 2/17/16: L, PSEC, ZFGN

|
Includes: AMZN, CATY, ECIA, FB, FDC, FRT, GOOG, HON, L, MB, PRU, PSEC, PTI, SHLD, TDG, TE, ZFGN
by: InsiderInsights

Summary

Tables of the top insider purchases and sales filed with the SEC on 2/17/16, based on dollar value.

Dollar values often do not equate with significance when it comes to insider trades.

Proprietary Insider Company Ratings are relayed to clarify significance.

Dollar value is only one metric to assess the significance of an insider transaction, but when high dollar value intersects with significance, it spotlights a stock investors should take the time to consider. InsiderInsights Daily Round Up articles are intended as initial research tools, so investors can separate real insider investment intelligence from time-wasting noise.

Click the Company Name links in the tables below to analyze a company's or insider's full insider history.

On Today's Tables:

Insider trades were rated Significant at:

  • Prospect Capital Corp. (NASDAQ:PSEC), and;
  • Loews Corp. (NYSE:L).

Insider trades were rated Nearly Significant at:

  • Zafgen, Inc. (NASDAQ:ZFGN).

Insider trades were considered Insignificant at:

  • Prudential Financial, Inc. (NYSE:PRU);
  • First Data Corp. (NYSE:FDC);
  • Encision, Inc. (OTCPK:ECIA);
  • TECO Energy (NYSE:TE);
  • Alphabet Inc. (NASDAQ:GOOG);
  • Federal Realty Investment Trust (NYSE:FRT);
  • Facebook (NASDAQ:FB);
  • Cathay Gen Bancorp (NASDAQ:CATY), and;
  • Amazon.com, Inc. (NASDAQ:AMZN).

There is a Conflicted Insider Signal (both purchases and sales) at:

  • Transdigm Group Inc. (NYSE:TDG);
  • Sears Holdings Corp. (NASDAQ:SHLD);
  • Mindbody (NASDAQ:MB), and;
  • Honeywell International (NYSE:HON).

There is an IPO at:

  • Proteostasis Therapeutics (NASDAQ:PTI).

It's difficult to argue significance for most transactions made during IPOs.

Insider Purchases
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1 Small Robert J DIR Transdigm Group Inc. TDG B $99,484,541
2 New Enterprise BO Proteostasis Therapeutics PTI JB* $7,202,592
3 Barry John F CEO,DIR Prospect Capital Corp. PSEC B $6,502,317
4 Novartis Bioventures BO Proteostasis Therapeutics PTI JB* $3,000,000
5 Abdiel Capital Mgt BO Mindbody MB B $2,359,477
6 Bisignano Frank CEO,DIR First Data Corp. FDC JB* $1,195,584
7 Berkowitz Bruce R BO Sears Holdings Corp. SHLD B $557,450
8 Scovanner Douglas A DIR Prudential Financial, Inc. PRU B $462,944
9 Trudel Gregory J CEO,DIR Encision, Inc. ECIA JB* $450,000
10 Flynn James E BO Zafgen, Inc. ZFGN B $403,187
Click to enlarge

Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes:
B = Open-market Buy; AB = 10b5-1 (automatic) Buy; JB* = Buy indicated as being open-market, but not confirmed by trading price range and volume for the session.

Insider Sales
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1 Cote David M CB,CEO Honeywell International HON S $36,166,008
2 Brin Sergey PR,DIR,BO Alphabet Inc. GOOG AS $23,222,140
3 Cox Christopher K O Facebook FB AS $6,790,533
4 Piacentini Diego VP Amazon.com, Inc. AMZN AS $6,238,390
5 Tisch Andrew H PR,DIR Loews Corp. L S $4,846,487
6 Wehner David M CFO Facebook FB JS* $3,242,271
7 Ramil John B CEO,DIR TECO Energy TE AS $3,190,179
8 Blackburn Jeffrey VP Amazon.com, Inc. AMZN AS $3,184,053
9 Wood Donald C TT,CEO,DIR Federal Realty Investment Trust FRT S $3,068,573
10 Tang Anthony M VCB,DIR Cathay Gen Bancorp CATY S $2,754,550
Click to enlarge

InsiderInsights.com | Key to Insider Title and Trans Type Codes:
S = Open-market Sale; AS = 10b5-1 (automatic) Sale; JS* = Sale indicated as being open-market, but not confirmed by trading price range and volume for the session.

Did you miss our Previous Daily Round Up?

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Editor's Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.